Bryan Hambley

Hematology | Oncology
3229 Burnet Ave
Cincinnati, OH 45229

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications

The great imitator: Tuberculosis with lymphadenopathy and splenomegaly.

The great imitator: Tuberculosis with lymphadenopathy and splenomegaly.

Journal: IDCases
Published: December 21, 2023

The Coagulopathy of Acute Promyelocytic Leukemia: An Updated Review of Pathophysiology, Risk Stratification, and Clinical Management.

The Coagulopathy of Acute Promyelocytic Leukemia: An Updated Review of Pathophysiology, Risk Stratification, and Clinical Management.

Journal: Cancers
Published: June 02, 2023

Reversal of life-threatening bleeding with protamine sulfate in a patient with plasma cell leukemia.

Reversal of life-threatening bleeding with protamine sulfate in a patient with plasma cell leukemia.

Journal: Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis
Published: August 10, 2022

Membrane bending and sphingomyelinase-associated, sulfatide-dependent hypoxic adhesion of sickle mature erythrocytes.

Membrane bending and sphingomyelinase-associated, sulfatide-dependent hypoxic adhesion of sickle mature erythrocytes.

Journal: Blood advances
Published: June 22, 2022

Editorial: Modern Approaches to Hemophilia Management: Gene Therapy and Beyond.

Editorial: Modern Approaches to Hemophilia Management: Gene Therapy and Beyond.

Journal: Frontiers in medicine
Published: January 21, 2022

Donor Clonal Hematopoiesis and Recipient Outcomes After Transplantation.

Donor Clonal Hematopoiesis and Recipient Outcomes After Transplantation.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: November 18, 2021

Impact of diagnostic genetics on remission MRD and transplantation outcomes in older patients with AML.

Impact of diagnostic genetics on remission MRD and transplantation outcomes in older patients with AML.

Journal: Blood
Published: October 28, 2021

Arsenic trioxide dose capping to decrease toxicity in the treatment of acute promyelocytic leukemia.

Arsenic trioxide dose capping to decrease toxicity in the treatment of acute promyelocytic leukemia.

Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
Published: June 17, 2021

Coagulopathy in Acute Promyelocytic Leukemia: Can We Go Beyond Supportive Care?

Coagulopathy in Acute Promyelocytic Leukemia: Can We Go Beyond Supportive Care?

Journal: Frontiers in medicine
Published: June 09, 2021

Systems controls are needed to reduce mistaken tests for hemophagocytic lymphohistiocytosis, results of a prospective quality-improvement cohort study.

Systems controls are needed to reduce mistaken tests for hemophagocytic lymphohistiocytosis, results of a prospective quality-improvement cohort study.

Journal: Medicine
Published: March 15, 2021

Increased body mass index is a risk factor for acute promyelocytic leukemia.

Increased body mass index is a risk factor for acute promyelocytic leukemia.

Journal: EJHaem
Published: March 11, 2021

FLT3-ITD Allelic Burden and Acute Promyelocytic Leukemia Risk Stratification.

FLT3-ITD Allelic Burden and Acute Promyelocytic Leukemia Risk Stratification.

Journal: Biology
Published: February 09, 2021
Showing 1-12 of 21

Last Updated: 09/26/2026